Authors : Anurag Kumar Kannaujiya; Dr. Swarup J Chattarjee; Anshika Dubey

Volume/Issue : Volume 9 - 2024, Issue 12 - December

Google Scholar : https://tinyurl.com/4chy47up

Scribd : https://tinyurl.com/3286td5v

DOI : https://doi.org/10.5281/zenodo.14525326

Abstract : The role of 3D printing has started to play in pharmacy, and this represents transformative innovation that holds promising potential for the customization and enhancement of pharmaceutical products. The technology allows the creation of drug delivery systems, personal medications, and dosage forms tailored toward individual patient needs. It allows 3D printing complex drug structures: combinations of drugs, control release formulations, and even patient-specific shapes and sizes using CAD and additive manufacturing techniques. This allows more accurate dosing, enhances compliance of the patients, and reduces errors in medication. It also accelerates the development and test process for new drug formulations by streamlining production processes and costs. Although some major challenges such as regulatory issues, material limitations, and technological barriers exist, integration of 3D printing into pharmacy holds tremendous potential and promise in revolutionizing personalized medicine and pharmaceutical manufacturing. This paper elaborates the advancements, applications, and future potential of 3D printing in pharmaceutical sciences regarding formulation of drugs, delivery systems, and patient- centered care.

References :

1. Nayyar, A., & Kumar, A.: A roadmap to industry 4.0: smart production, sharp business and sustainable development. Berlin: Springer (2020).
2. Andreadis, I.I., Gioumouxouzis, C.I., Eleftheriadis, G.K., Fatouros, D.G.: The Advent of a New Era in Digital Healthcare: A Role for 3D Printing Technologies in Drug Manufacturing? Pharmaceutics 14,(2022). https://doi.org/10.3390/pharmaceutics14030609.
3. Kumar, A., Nayyar, A.: si3-Industry: A Sustainable, Intelligent, Innovative, Internet-of-Things Industry, in: Nayyar, A., Kumar, A. (Eds.), A Roadmap to Industry 4.0: Smart Production, Sharp Business and Sustainable Development. Springer International Publishing, Cham, pp. 1–21 (2020) https://doi.org/10.1007/978-3-030-14544-6_1.
4. Jamróz, W., Szafraniec, J., Kurek, M., & Jachowicz, R.: 3D Printing in Pharmaceutical and Medical Applications – Recent Achievements and Challenges. Pharmaceutical Research, 35(9), 176 (2018). https://doi.org/10.1007/s11095-018-2454-x.
5. Hole, G., Hole, A.S., McFalone-Shaw, I.: Digitalization in pharmaceutical industry: What to focus on under the digital implementation process? International Journal of Pharmaceutics: X 3 (2021). 100095. https://doi.org/10.1016/j.ijpx.2021.100095.
6. Reinhardt, I.C., Oliveira, J., Ring, D.: Industry 4.0 and the Future of the Pharmaceutical Industry. Pharmaceutical Engineering 41 (2021).
7. Elbadawi, M., McCoubrey, L.E., Gavins, F.K.H., Ong, J.J., Goyanes, A., Gaisford, S., Basit, A.W.: Harnessing artificial intelligence for the next generation of 3D printed medicines. Advanced Drug Delivery Reviews 175, 113805 (2021). https://doi.org/10.1016/j.addr.2021.05.015.
8. Samiei, N.: Recent trends on applications of 3D printing technology on the design and manufacture of pharmaceutical oral formulation: A mini review. Beni-Suef University Journal of Basic and Applied Sciences, 9(1), 12 (2020). https://doi.org/10.1186/s43088-020-00040-4.
9. Ali, A., Ahmad, U., & Akhtar, J.: 3D Printing in Pharmaceutical Sector: An Overview. In Pharmaceutical Formulation Design—Recent Practices. IntechOpen. (2020). https://doi.org/10.5772/intechopen.90738.
10. Pucci, Josephine U., Christophe, Brandon R., Sisti, Jonathan A., Connolly, Edward S.: Three-dimensional printing: technologies, applications, and limitations in neurosurgery. Biotechnol. Adv. 35 (5), 521–529 (2017). 10.1016/j. biotechadv.2017.05.007.
11. Azad, M.A., Olawuni, D., Kimbell, G., Badruddoza, A.Z.M., Hossain, M.S., Sultana, T.: Polymers for extrusion-based 3D printing of pharmaceuticals: A holistic materials–process perspective. Pharmaceutics. 12(2), 124 (2020). https://doi.org/10.3390/pharmaceutics12020124.
12. Warsi, M.H., Yusuf, M., Al Robaian, M., Khan, M., Muheem, A., Khan, S.: 3D Printing Methods for Pharmaceutical Manufacturing: Opportunity and Challenges. Curr. Pharm. Des. 24 (42), 4949–4956 (2018). https://doi.org/10.2174/1381612825666181206121701.
13. Pandey, M., Choudhury, H., Fern, J. L. C., Kee, A. T. K., Kou, J., Jing, J. L. J., Her, H. C., Yong, H. S., Ming, H. C., Bhattamisra, S. K., & Gorain, B.: 3D printing for oral drug delivery: A new tool to customize drug delivery. Drug Delivery and Translational Research, 10(4), 986—1001 (2020). https://doi.org/10.1007/s13346-020-00737-0.
14. Wallis, M., Al-Dulimi, Z., Tan, D. K., Maniruzzaman, M., & Nokhodchi, A.: 3D printing for enhanced drug delivery: Current state-of-the-art and challenges. Drug Development and Industrial Pharmacy, 46(9), 1385–1401 (2020). https://doi.org/10.1080/03639045.2020.1801714.
15. Jose, P. A., & Gv, P. C.: 3D printing of pharmaceuticals – a potential technology in developing personalized medicine. Asian Journal of Pharmaceutical Research and Development, 6(3), 46–54 (2018).  https://doi.org/10.22270/ ajprd.v6i3.375.
16. Awad, A., Fina, F., Goyanes, A., Gaisford, S., & Basit, A. W.: 3D printing: Principles and pharmaceutical applications of selective laser sintering. International Journal of Pharmaceutics, 586, 119594 (2020).  https://doi.org/10.1016/ j.ijpharm.2020.119594.
17. Cui, X., Boland, T., D’Lima, D. D., & Lotz, M. K.: Thermal Inkjet Printing in Tissue Engineering and Regenerative Medicine. Recent Patents on Drug Delivery & Formulation, 6(2), 149–155 (2012).
18. Chen, A. (n.d.). Benefits vs drawbacks of 3D printing in the Pharmaceutical industry. Retrieved August 14, (2021). https://www.cmac.com.au/blog/benefits-drawbacks-3d-printing-pharmaceutical-industry.
19. Gujrati, A., Sharma, A., & Mahajan, S. C.: Review on Applications of 3D Printing in Pharmaceuticals. 25, 7 (2019).
20. Ponni, R., Swamivelmanickam, M., & Sivakrishnan, S. (2020). 3D Printing in Pharmaceutical Technology – A Review. International journal of pharmaceutical investigation, 10, 8–12.
21. Islam, R., & Sadhukhan, P.: An Insight of 3d Printing Technology in Pharmaceutical Development and Application: An Updated Review. Current trends in Pharmaceutical Research 7, 55–80 (2021).
22. Wong, S: 3D printing: Risks vs. benefits for the pharma industry (United Kingdom) [Text]. PharmaTimes; PharmaTimes Media Limited. (2018, May 29). http://www.pharmatimes.com/web_exclusives/3d_printing_risks_vs._benefits_for_the_pharma_industry_1237380.
23. Mwema, F. M., & Akinlabi, E. T.: Basics of Fused Deposition Modelling (FDM). Fused Deposition Modeling, 1–15 (2020). https://doi.org/10.1007/978-3-030-48259-6_1.
24. Melocchi, A., Parietti, F., Maroni, A., Foppoli, A., Gazzaniga, A., & Zema, L.: Hot-melt extruded filaments based on pharmaceutical grade polymers for 3D printing by fused deposition modeling. International Journal of Pharmaceutics, 509(1), 255–263 (2016).  https://doi.org/10.1016/ j.ijpharm.2016.05.036.
25. Gao, X., Yu, N., & Li, J.: Influence of printing parameters and filament quality on structure and properties of polymer composite components used in the fields of automotive. In K. Friedrich, R. Walter, C. Soutis, S. G. Advani, & I. H. B. Fiedler (Eds.), Structure and Properties of Additive Manufactured Polymer Components. Woodhead Publishing. pp. 303–330 (2020). https://doi.org/10.1016/B978-0-12-819535-2.00010-7.
26. Esposito Corcione, C., Gervaso, F., Scalera, F., Padmanabhan, S. K., Madaghiele, M., Montagna, F., Sannino, A., Licciulli, A., & Maffezzoli, A.: Highly loaded hydroxyapatite microsphere/P.L.A. porous scaffolds obtained by fused deposition modelling. Ceramics International, 45(2, Part B), 2803–2810 (2019).  https://doi.org/10.1016/ j.ceramint.2018.07.297.
27. Giri, B. R., Song, E. S., Kwon, J., Lee, J.-H., Park, J.-B., & Kim, D. W.: Fabrication of Intragastric Floating, Controlled Release 3D Printed Theophylline Tablets Using Hot-Melt Extrusion and Fused Deposition Modeling. Pharmaceutics, 12(1), 77(2020). https://doi.org/10.3390/pharmaceutics12010077.
28. Skowyra, J., Pietrzak, K., & Alhnan, M. A.: Fabrication of extended-release patient-tailored prednisolone tablets via fused deposition modelling (FDM) 3D printing. European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences, 68, 11–17 (2015).  https://doi.org/10.1016/ j.ejps.2014.11.009.
29. Hussain, A., Mahmood, F., Arshad, M. S., Abbas, N., Qamar, N., Mudassir, J., Farhaj, S., Nirwan, J. S., & Ghori, M. U.: Personalised 3D Printed Fast-Dissolving Tablets for Managing Hypertensive Crisis: In-Vitro/In-Vivo Studies. Polymers, 12(12), 3057 (2020).  https://doi.org/10.3390/polym 12123057.
30. Goyanes, A., Chang, H., Sedough, D., Hatton, G., Wang, J., Buanz, A., Gaisford, S., & Basit, A.: Fabrication of controlled-release budesonide tablets via desktop (FDM) 3D printing. International Journal of Pharmaceutics, 496 (2015).  https://doi.org/10.1016/j.ijpharm.2015.10.039